- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA to hold medical software hearing
The Food and Drug Administration and the National Library of Medicinehave scheduled a workshop in September to discuss the FDA's regulationof medical software. The meeting is intended to clarify confusionregarding requirements that apply to medical
The Food and Drug Administration and the National Library of Medicinehave scheduled a workshop in September to discuss the FDA's regulationof medical software. The meeting is intended to clarify confusionregarding requirements that apply to medical software devicesand accessories, according to the agency.
The workshop is scheduled for Sept. 3 and 4 at the NationalInstitutes of Health, Natcher Conference Center, 45 Center Dr.,Bethesda, MD. For more information contact Charles Furfine ofthe FDA's Center for Devices and Radiological Health at 301/443-2536,ext. 16. Information related to the workshop can also be accessedon the FDA's World Wide Web home page at http://www.fda.gov.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
